New MRI technique could revolutionize lung disease monitoring
NCT ID NCT07300696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether functional MRI can help doctors tell different types of interstitial lung disease apart and track how they change over time. About 200 adults with certain lung conditions will get MRI scans alongside standard CT scans. The goal is to see if MRI can provide useful information without using radiation, potentially improving how these diseases are diagnosed and monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY PNEUMONITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thoraxklink Heidelberg - Universitätsklinikum Heidelberg
RECRUITINGHeidelberg, 69126, Germany
-
Universitätsklinikum Schleswig-Holstein, Campus Kiel
ACTIVE_NOT_RECRUITINGKiel, 24105, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can umbilical cord stem cells ease a scarring lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care